Our results revealed that both JQ1 and TEM significantly enhanced cisplatin-induced growth inhibition in MB cells, suggesting that inhibition of MYCN/mTOR signaling not only inhibits cell proliferation and survival of NB cells, but also sensitizes NB cells to chemotherapy. This evidence concerns the gene MTOR and neuroblastoma.